Efficacy of statins in patients with diabetic nephropathy: a meta-analysis of randomized controlled trialsReportar como inadecuado




Efficacy of statins in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Lipids in Health and Disease

, 15:179

First Online: 12 October 2016Received: 08 September 2016Accepted: 07 October 2016

Abstract

BackgroundThe effects of statins in patients with diabetic nephropathy are controversial. With increasing interest in the potential therapeutic role of statins in diabetic nephropathy, it is essential to evaluate its real effects.

MethodsPubMed, EMBASE, Web of Science databases, Cochrane Central Register of Controlled Trials and China National Knowledge Infrastructure were systematically searched for randomized controlled trials RCTs of statins in patients with diabetic nephropathy.

ResultsFourteen trials with 2866 participants were included in our meta-analysis. Compared with placebo, albuminuria and urinary albumin excretion rates in the statin group were reduced by 0.46 95 % confidence interval CI,−0.68 to −0.25, P < 0.0001 and 1.68 95 % CI, −3.23 to −0.12, P = 0.03, respectively. The reduction of albuminuria was greater in patients of type 2 diabetes mellitus with diabetic nephropathy standardized mean difference SMD, −0.56; 95 % CI, −0.80 to −0.32, P < 0.00001 and the decrease was significant during the 1 to 3 years period of statin therapy SMD, −0.57; 95 % CI, −0.95 to −0.19, P = 0.003. Subgroup analysis demonstrated the effects of statins were much stronger in subjects with pathologic albuminuria: change of −0.71 95 % CI, −1.09 to −0.33, P = 0.0003 for those with urinary protein excretion 30 to 300 mg-day, −0.37 95 % CI, −0.67 to −0.06, P = 0.02 for those with excretion more than 300 mg-day and −0.29 95 % CI, −0.78 to 0.21, P = 0.26 for those with excretion less than 30 mg-day. In contrast, statins did not significantly reduce estimated glomerular filtration rate, serum creatinine and blood urea nitrogen levels.

ConclusionsStatins decrease the albuminuria and urinary albumin excretion rates significantly. The efficacy of statins on renal function is time dependent and better in type 2 diabetic patients with nephropathy.

KeywordsStatins Diabetic Nephropathy Meta-analysis  Download fulltext PDF



Autor: Xue Shen - Zhongwen Zhang - Xiaoqian Zhang - Junyu Zhao - Xiaojun Zhou - Qinglei Xu - Hongxia Shang - Jianjun Dong - Lin 

Fuente: https://link.springer.com/



DESCARGAR PDF




Documentos relacionados